Federation Des Caisses Desjardins Du Quebec Caribou Biosciences, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 900 shares of CRBU stock, worth $1,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
900
Previous 900
-0.0%
Holding current value
$1,215
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRBU
# of Institutions
141Shares Held
52.8MCall Options Held
157KPut Options Held
99.7K-
Black Rock Inc. New York, NY6.95MShares$9.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$6.16 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$5.23 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$3.71 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$3.37 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $82.1M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...